FDA Inspection 947009 — Fresenius Kabi Austria GMBH

Fresenius Kabi Austria GMBH — FEI 3003708554

The FDA completed an inspection of Fresenius Kabi Austria GMBH on June 19, 2015 in Graz. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 19, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Graz (Austria)

Citations

IDCFRDescription
440221 CFR 211.192Written record of investigation incomplete
440421 CFR 211.194(a)(1)Sample identification and other information